Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
To Be or Not to Be: Navigating the Influence of Micrornas on Cervical Cancer Cell Death Publisher



Taghizadieh M1 ; Kalantari M2 ; Bakhshali R3 ; Kobravi S4 ; Khalilollah S5 ; Baghi HB6 ; Bayat M6 ; Nahand JS6 ; Akhavansigari R7, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pathology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  2. 2. Department of Biology, Tehran University of health Sciences, Tehran, Iran
  3. 3. Omid Cancer Center, Ahvaz, Iran
  4. 4. Department of Oral & Maxillofacial Surgery, Faculty of Dentistry, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
  5. 5. Department of Neurosurgery, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  6. 6. Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  7. 7. Department of Neurosurgery, University Medical Center Tuebingen, Tuebingen, Germany
  8. 8. Department of Health Care Management and Clinical Research, Collegium Humanum Warsaw Management University, Warsaw, Poland

Source: Cancer Cell International Published:2025


Abstract

With all diagnostic and therapeutic advances, such as surgery, radiation- and chemo-therapy, cervical cancer (CC) is still ranked fourth among the most frequent cancers in women globally. New biomarkers and therapeutic targets are warranted to be discovered for the early detection, treatment, and prognosis of CC. As component of the non-coding RNA’s family, microRNAs (miRNAs) participate in several cellular functions such as cell proliferation, gene expression, many signaling cascades, apoptosis, angiogenesis, etc. MiRNAs can suppress or induce programmed cell death (PCD) pathways by altering their regulatory genes. Besides, abnormal expression of miRNAs weakens or promotes various signaling pathways associated with PCD, resulting in the development of human diseases such as CC. For that reason, understanding the effects that miRNAs exert on the various modes of tumor PCD, and evaluating the potential of miRNAs to serve as targets for induction of cell death and reappearance of chemotherapy. The current study aims to define the effect that miRNAs exert on cell apoptosis, autophagy, pyroptosis, ferroptosis, and anoikis in cervical cancer to investigate possible targets for cervical cancer therapy. Manipulating the PCD pathways by miRNAs could be considered a primary therapeutic strategy for cervical cancer. © The Author(s) 2025.
Other Related Docs
9. Micrornas and Exosomes: Cardiac Stem Cells in Heart Diseases, Pathology Research and Practice (2022)
10. Cell Death Pathways and Viruses: Role of Micrornas, Molecular Therapy Nucleic Acids (2021)
13. Anti-Tumor Activities of Probiotics in Cervical Cancer, Journal of Ovarian Research (2020)
16. Lipidomics-Driven Drug Discovery and Delivery Strategies in Glioblastoma, Biochimica et Biophysica Acta - Molecular Basis of Disease (2025)
20. Liquid Biopsy in Female Genital Tract (Ovarian Cancer, Endometrial Tumor, and Cervical Tumor), Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
22. The Question of Survival or Death: What Is the Role of Autophagy in Acute Myeloid Leukemia (Aml)?, International Journal of Hematology-Oncology and Stem Cell Research (2022)
23. The Tumor Microenvironment's Gambit: Exosomal Pawns on the Board of Head and Neck Cancer, Biochimica et Biophysica Acta - Reviews on Cancer (2024)
25. Programmed Cell Death and Melatonin: A Comprehensive Review, Functional and Integrative Genomics (2024)
27. Emerging Role of Mirnas in the Regulation of Ferroptosis, Frontiers in Molecular Biosciences (2023)
35. Critical Roles of Mir-21 in Promotions Angiogenesis: Friend or Foe?, Clinical and Experimental Medicine (2025)
37. Microrna a New Gate in Cancer and Human Disease: A Review, Journal of Biological Sciences (2017)
44. Targeting Mirna by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver, Evidence-based Complementary and Alternative Medicine (2021)